Trial intelligence / Profile preview

Pyridorin in Diabetic Nephropathy

NCT00734253Phase 2Completed

Sponsor
NephroGenex
Start
Aug 2008
Primary completion
Aug 2010
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of pyridorin in diabetic nephropathy (DN), sponsored by NephroGenex. Started Aug 2008; status: completed.

02

Drugs

pyridorin
03

Conditions

diabetic nephropathy (DN)

Beyond the preview

Go deeper on NCT00734253.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00734253.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call